Search Results

Press Releases

ViroCell Biologics Expands U.S. Business Development Team With Two New Appointments

December 16, 2024

·

3 min read

Pharm Country

ViroCell to present at 2024 Cell & Gene Meeting on the Med

ViroCell Biologics announces that John W. Hadden II, Chief Executive Officer, will be presenting at the annual Cell & Gene Meeting on the Med to be held April 9-11 in Rome, Italy.

April 8, 2024

·

3 min read

Press Releases

ViroCell Biologics to Host Panel Event at 2024 Cell & Gene Meeting on the Mesa

October 7, 2024

·

3 min read

Pharm Country

ViroCell Signs Manufacturing Services Agreement with UCL to Accelerate Research Into Prevention of Relapse in Childhood Blood Cancer

ViroCell Biologics announces a new partnership with University College London to advance Professor Persis Amrolia’s innovative chimeric antigen receptor T-cell therapy for relapsed paediatric acute lymphoblastic leukaemia.

December 12, 2023

·

4 min read

Business

ViroCell Appoints Brian Collins as CFO

ViroCell Biologics, a specialist Contract Development and Manufacturing Organisation in cell and gene therapy clinical trials, announces the appointment of Brian Collins as Chief Financial Officer.

July 26, 2023

·

3 min read

Pharm Country

ViroCell Expands Business Development Team to Support Next Phase of Growth

ViroCell Biologics, a specialist contract development and manufacturing organisation in cell and gene therapy clinical trials, announces the appointment of Traci Kyes as Vice President of Business Development and Makis Sigalas as Senior Business Development Director.

October 4, 2023

·

5 min read

Pharm Country

ViroCell and Great Ormond Street Hospital Poised to Unlock Clinical Trial ‘Backlog’ Following MHRA Manufacturing Approval

ViroCell Biologics announces that the Company is now able to manufacture and globally export viral vectors from Great Ormond Street Hospital’s state-of-the-art manufacturing facility, the Zayed Centre for Research, for use in clinical trials.

November 1, 2023

·

5 min read

Global Roundup: Partnership Aims to Bolster Drug Discovery in Africa

Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

September 29, 2021

·

9 min read

·

Alex Keown

Business

Ligand Pharmaceuticals Names Director Todd C. Davis as CEO

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that John Higgins has retired as Chief Executive Officer, effective as of today, and that the company’s board of directors has named Todd C. Davis as Chief Executive Officer.

December 5, 2022

·

7 min read

Business

BioSpace Movers & Shakers, Aug. 20

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

August 19, 2021

·

8 min read

·

Alex Keown